source
- GSK to cut 650 jobs as it shuts German vaccine plant and consolidates production in CanadaGSK announced it will close its vaccine manufacturing facility in Dresden, Germany, resulting in about 650 layoffs. The decision follows a review and aligns with a $2.5 billion cost‑saving program…
- Connect Biopharma's asthma drug rademikibart misses primary endpoint in Phase 2 trialConnect Biopharma reported that its IL-4/IL-13 blocker rademikibart failed to meet the primary endpoint in a Phase 2 study in asthma patients with type-2 inflammation. The trial enrolled 160 patie…